Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.

Lacey CA, Chambers CA, Mitchell WJ, Skyberg JA.

J Leukoc Biol. 2019 Jul;106(1):27-34. doi: 10.1002/JLB.4MIA1018-409R. Epub 2019 Feb 12.

PMID:
30748031
2.

Caspase-1 and Caspase-11 Mediate Pyroptosis, Inflammation, and Control of Brucella Joint Infection.

Lacey CA, Mitchell WJ, Dadelahi AS, Skyberg JA.

Infect Immun. 2018 Aug 22;86(9). pii: e00361-18. doi: 10.1128/IAI.00361-18. Print 2018 Sep.

3.

Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Skyberg JA, Lacey CA.

J Leukoc Biol. 2017 Dec;102(6):1441-1450. doi: 10.1189/jlb.4A0517-179R. Epub 2017 Sep 26.

4.

Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.

Lacey CA, Mitchell WJ, Brown CR, Skyberg JA.

Infect Immun. 2017 Feb 23;85(3). pii: e00961-16. doi: 10.1128/IAI.00961-16. Print 2017 Mar.

5.

Activation of bovine neutrophils by Brucella spp.

Keleher LL, Skyberg JA.

Vet Immunol Immunopathol. 2016 Sep;177:1-6. doi: 10.1016/j.vetimm.2016.05.011. Epub 2016 May 24.

PMID:
27436438
6.

CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.

Lacey CA, Keleher LL, Mitchell WJ, Brown CR, Skyberg JA.

J Infect Dis. 2016 Jul 1;214(1):151-60. doi: 10.1093/infdis/jiw087. Epub 2016 Mar 6.

7.

Immunopotentiation for bacterial biodefense.

Skyberg JA.

Curr Top Med Chem. 2014;14(18):2115-26. Review.

PMID:
25373479
8.

Immunotherapy for tularemia.

Skyberg JA.

Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19. Review.

9.

Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.

Infect Immun. 2013 Sep;81(9):3099-105. doi: 10.1128/IAI.00203-13. Epub 2013 Jun 17.

10.

Progress in Brucella vaccine development.

Yang X, Skyberg JA, Cao L, Clapp B, Thornburg T, Pascual DW.

Front Biol (Beijing). 2013 Feb 1;8(1):60-77.

11.

IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Skyberg JA, Thornburg T, Kochetkova I, Layton W, Callis G, Rollins MF, Riccardi C, Becker T, Golden S, Pascual DW.

J Leukoc Biol. 2012 Aug;92(2):375-87. doi: 10.1189/jlb.1211626. Epub 2012 May 25.

12.

Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.

Skyberg JA, Rollins MF, Holderness JS, Marlenee NL, Schepetkin IA, Goodyear A, Dow SW, Jutila MA, Pascual DW.

PLoS Pathog. 2012;8(3):e1002587. doi: 10.1371/journal.ppat.1002587. Epub 2012 Mar 15.

13.

Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.

Huarte E, Rynda-Apple A, Riccardi C, Skyberg JA, Golden S, Rollins MF, Ramstead AG, Jackiw LO, Maddaloni M, Pascual DW.

J Autoimmun. 2011 Dec;37(4):328-41. doi: 10.1016/j.jaut.2011.09.005. Epub 2011 Oct 22.

14.

Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Clapp B, Skyberg JA, Yang X, Thornburg T, Walters N, Pascual DW.

Infect Immun. 2011 Oct;79(10):4165-74. doi: 10.1128/IAI.05080-11. Epub 2011 Jul 18.

15.

Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.

Skyberg JA, Thornburg T, Rollins M, Huarte E, Jutila MA, Pascual DW.

PLoS One. 2011;6(7):e21978. doi: 10.1371/journal.pone.0021978. Epub 2011 Jul 12.

16.

Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.

Skyberg JA, Robison A, Golden S, Rollins MF, Callis G, Huarte E, Kochetkova I, Jutila MA, Pascual DW.

J Leukoc Biol. 2011 Dec;90(6):1043-54. doi: 10.1189/jlb.0311168. Epub 2011 Jun 21.

17.

Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Rynda-Apple A, Huarte E, Maddaloni M, Callis G, Skyberg JA, Pascual DW.

Eur J Immunol. 2011 Feb;41(2):313-23. doi: 10.1002/eji.201041104. Epub 2010 Dec 29.

18.

Mutational and transcriptional analyses of an avian pathogenic Escherichia coli ColV plasmid.

Skyberg JA, Johnson TJ, Nolan LK.

BMC Microbiol. 2008 Jan 29;8:24. doi: 10.1186/1471-2180-8-24.

19.

Characterization of a series of transconjugant mutants of an avian pathogenic Escherichia coli isolate for resistance to serum complement.

Lynne AM, Skyberg JA, Logue CM, Doetkott C, Foley SL, Nolan LK.

Avian Dis. 2007 Sep;51(3):771-6.

PMID:
17992940
20.

Detection of Iss and Bor on the surface of Escherichia coli.

Lynne AM, Skyberg JA, Logue CM, Nolan LK.

J Appl Microbiol. 2007 Mar;102(3):660-6.

21.

The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes.

Johnson TJ, Kariyawasam S, Wannemuehler Y, Mangiamele P, Johnson SJ, Doetkott C, Skyberg JA, Lynne AM, Johnson JR, Nolan LK.

J Bacteriol. 2007 Apr;189(8):3228-36. Epub 2007 Feb 9. Erratum in: J Bacteriol. 2007 Jun;189(12):4554.

22.

Biofilm formation by avian Escherichia coli in relation to media, source and phylogeny.

Skyberg JA, Siek KE, Doetkott C, Nolan LK.

J Appl Microbiol. 2007 Feb;102(2):548-54.

23.
24.

Virulence genotyping of Salmonella spp. with multiplex PCR.

Skyberg JA, Logue CM, Nolan LK.

Avian Dis. 2006 Mar;50(1):77-81.

PMID:
16617986
25.

Antimicrobial susceptibility and characterization of Salmonella isolates from processed bison carcasses.

Li Q, Skyberg JA, Fakhr MK, Sherwood JS, Nolan LK, Logue CM.

Appl Environ Microbiol. 2006 Apr;72(4):3046-9.

26.

Characterizing avian Escherichia coli isolates with multiplex polymerase chain reaction.

Skyberg JA, Horne SM, Giddings CW, Wooley RE, Gibbs PS, Nolan LK.

Avian Dis. 2003 Oct-Dec;47(4):1441-7.

PMID:
14708994

Supplemental Content

Loading ...
Support Center